---
figid: PMC8234904__biomolecules-11-00893-g002
figtitle: 'Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related
  to the Epithelial-Mesenchymal Transition'
organisms:
- Mus musculus
- Rattus norvegicus
- Nicotiana tabacum
- Taxus brevifolia
- Homo sapiens
pmcid: PMC8234904
filename: biomolecules-11-00893-g002.jpg
figlink: /pmc/articles/PMC8234904/figure/biomolecules-11-00893-f002/
number: F2
caption: 'A diagram of the NF-κB (canonical), PI3K/AKT, and TGF-β pathways. NF-κB
  is shown in the figure as a heterodimer consisting of p65 and p50 subunits. In the
  canonical pathway, NF-κB is bound and inhibited by IκBα proteins. Binding of proinflammatory
  cytokines, such as TNF-α, to specific transmembrane receptors activates the IKKβ
  protein, which phosphorylates IκBα and leads to its ubiquitination and, finally,
  to proteasomal degradation. In this process, ROS interact with NF-κB in various
  ways, such as by activating IKKβ or IκBα phosphorylation. The active NF-κB complex
  translocates to the nucleus. For optimal activation of the transcription of NF-κB
  for certain target genes, interaction with CBP or p300 is required [,]. PI3K consists
  of two domains, p110 and p85, but its activation requires adapter molecules, such
  as IRS1. Following activation and phosphorylation of the tyrosine kinase receptor
  (TKR) by growth factors, TKR will recruit PI3K, finally activating AKT by recruiting
  phosphoinositide-dependent kinase-1 (PDK1) to the kinase domain of AKT. AKT can
  subsequently affect downstream factors and activate mTORC1, thereby activating the
  entire pathway and regulating cell growth and apoptosis. AKT can also be activated
  by p38, which is controlled by the TGF-β pathway. Activated AKT inhibits IκBα and
  miR-200, while triggering IKKβ protein to further affect cell immunity, apoptosis,
  and proliferation []. In the TGF-β pathway, members of the TGF-β superfamily, such
  as TGF-β1, bind to the transmembrane receptor (TGF-β-R), resulting in phosphorylation
  of the cytoplasmic signaling molecules Smad2 and Smad3. The activated Smad2/3 bind
  to the signaling transducer, Smad4, and this newly formed complex translocates to
  the nucleus []. There is a great deal of crosstalk between these signaling pathways,
  and the translocation process can also be inhibited by peroxisome proliferator-activated
  receptor-γ (PPAR-γ), PTEN, or caspase-3. However, once the functions of the suppressors
  are inhibited, transcription factors, such as ZEB, vimentin, etc., will be activated
  and secreted into the extracellular environment, eventually leading to conversion
  of the microenvironment. p: phosphorylation, u: ubiquitination.'
papertitle: 'Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug
  Resistance Related to the Epithelial-Mesenchymal Transition.'
reftext: Jingjing Sha, et al. Biomolecules. 2021 Jun;11(6):893.
year: '2021'
doi: 10.3390/biom11060893
journal_title: Biomolecules
journal_nlm_ta: Biomolecules
publisher_name: MDPI
keywords: EMT | chemotherapy | chemoresistance | oral squamous cell carcinoma
automl_pathway: 0.9523857
figid_alias: PMC8234904__F2
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC8234904__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8234904__biomolecules-11-00893-g002.html
  '@type': Dataset
  description: 'A diagram of the NF-κB (canonical), PI3K/AKT, and TGF-β pathways.
    NF-κB is shown in the figure as a heterodimer consisting of p65 and p50 subunits.
    In the canonical pathway, NF-κB is bound and inhibited by IκBα proteins. Binding
    of proinflammatory cytokines, such as TNF-α, to specific transmembrane receptors
    activates the IKKβ protein, which phosphorylates IκBα and leads to its ubiquitination
    and, finally, to proteasomal degradation. In this process, ROS interact with NF-κB
    in various ways, such as by activating IKKβ or IκBα phosphorylation. The active
    NF-κB complex translocates to the nucleus. For optimal activation of the transcription
    of NF-κB for certain target genes, interaction with CBP or p300 is required [,].
    PI3K consists of two domains, p110 and p85, but its activation requires adapter
    molecules, such as IRS1. Following activation and phosphorylation of the tyrosine
    kinase receptor (TKR) by growth factors, TKR will recruit PI3K, finally activating
    AKT by recruiting phosphoinositide-dependent kinase-1 (PDK1) to the kinase domain
    of AKT. AKT can subsequently affect downstream factors and activate mTORC1, thereby
    activating the entire pathway and regulating cell growth and apoptosis. AKT can
    also be activated by p38, which is controlled by the TGF-β pathway. Activated
    AKT inhibits IκBα and miR-200, while triggering IKKβ protein to further affect
    cell immunity, apoptosis, and proliferation []. In the TGF-β pathway, members
    of the TGF-β superfamily, such as TGF-β1, bind to the transmembrane receptor (TGF-β-R),
    resulting in phosphorylation of the cytoplasmic signaling molecules Smad2 and
    Smad3. The activated Smad2/3 bind to the signaling transducer, Smad4, and this
    newly formed complex translocates to the nucleus []. There is a great deal of
    crosstalk between these signaling pathways, and the translocation process can
    also be inhibited by peroxisome proliferator-activated receptor-γ (PPAR-γ), PTEN,
    or caspase-3. However, once the functions of the suppressors are inhibited, transcription
    factors, such as ZEB, vimentin, etc., will be activated and secreted into the
    extracellular environment, eventually leading to conversion of the microenvironment.
    p: phosphorylation, u: ubiquitination.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tnf
  - Syt1
  - Nfkb1
  - Rela
  - Pdk1
  - Crebbp
  - Pag1
  - Akt1
  - Mapk14
  - Pten
  - Tgfb1
  - Smad2
  - Smad3
  - Smad4
  - Snai1
  - Il6
  - Twist1
  - Smad7
  - Ikbkb
  - Gorasp1
  - Rtn4
  - Cdc37
  - Lsp1
  - Pold2
  - Cd40
  - Dctn2
  - Pik3ca
  - Ecm1
  - Ppp1r13b
  - Pdpk1
  - Cytip
  - Ep300
  - Crk
  - Grap2
  - Syp
  - Ahsa1
  - Zeb1
  - Casp3
  - Cxcl15
  - TNF
  - IKBKB
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - NFKB1
  - RELB
  - REL
  - NFKB2
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - CUX1
  - SART3
  - PIK3R1
  - PIK3R2
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - PDK1
  - PDPK1
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - EP300
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RPTOR
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - PTEN
  - TGFB1
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - SMAD2
  - SMAD3
  - SMAD4
  - SNAI1
  - CXCL8
  - IL6
  - TWIST1
  - SMAD7
---
